Multicenter Registry of Patients With Subarachnoid Hemorrhage
ConditionSubarachnoid Hemorrhage, Spontaneous
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUMC Utrecht
About this trial
The purpose of this registry is to collect detailed information on the characteristics, treatment, and outcomes of patients with a subarachnoid hemorrhage. This information will enable research aimed at improving the safety and effectiveness of current and future treatments. By studying these data, the investigators aim to identify which treatment strategies offer the best results and which factors are most important in the care of patients with a subarachnoid hemorrhage. The knowledge gained from this research will help improve patient care in the future.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Spontaneous subarachnoid hemorrhage with blood in the basal cisterns and/or major fissures on non-contrast head computed tomography (CT), or xanthochromia of cerebrospinal fluid confirmed by spectrophotometric analysis.
Aneurysmal SAH
SAH from other intracranial vascular malformation (e.g. AVM, dural AVF)
Disqualifiers
Traumatic, neoplastic, infection related (except mycotic aneurysms), or iatrogenic SAH
Isolated convexity SAH
Trial design
Treatments tested in this trial
- None, observational study
Treatment groups
1,000 Participants
are divided into 1 treatment groupSponsors and collaborators
UMC Utrecht
Lead sponsor
Dutch Heart Foundation
Collaborator
The Dutch Brain Foundation
Collaborator
Radboud University Medical Center
Collaborator
Erasmus Medical Center
Collaborator
Maastricht University Medical Center
Collaborator
Elisabeth-TweeSteden Ziekenhuis
Collaborator
Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
Collaborator
Isala
Collaborator
Medical Center Haaglanden
Collaborator
University Medical Center Groningen
Collaborator
Source ClinicalTrials.gov